Related CAS #
68-35-9; 547-32-0 (Salt)
Synonym
Sulfadiazine sodium; NSC117870; NSC-117870; NSC 117870; Soludiazine; Sulphadiazine; Suthogen
IUPAC/Chemical Name
Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosodium salt
InChi Key
JLDCNMJPBBKAHH-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H9N4O2S.Na/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
SMILES Code
O=S(C1=CC=C(N)C=C1)([N-]C2=NC=CC=N2)=O.[Na+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
272.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Naser NA, Alasedi KM, Khan ZA. New approach for determination of sulfadiazine in pharmaceutical preparations using 4(4-sulphophenylazo)pyrogallol: Kinetic spectrophotometric method. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Aug 5;201:267-280. doi: 10.1016/j.saa.2018.05.012. Epub 2018 May 4. PMID: 29758513.
2: Berns AE, Philipp H, Lewandowski H, Choi JH, Lamshöft M, Narres HD. Interactions of 15N-Sulfadiazine and Soil Components As Evidenced by 15N-CPMAS NMR. Environ Sci Technol. 2018 Mar 20;52(6):3748-3757. doi: 10.1021/acs.est.7b06164. Epub 2018 Mar 1. PMID: 29465228.
3: Ventura MG, Wybran J, Farber CM. Sulfadiazine revisited. J Infect Dis. 1989 Sep;160(3):556-7. doi: 10.1093/infdis/160.3.556. PMID: 2760508.
4: Delrivo A, Aloisio C, Longhi MR, Granero G. Artificial Lipid Membrane Permeability Method for Predicting Intestinal Drug Transport: Probing the Determining Step in the Oral Absorption of Sulfadiazine; Influence of the Formation of Binary and Ternary Complexes with Cyclodextrins. AAPS PharmSciTech. 2018 Apr;19(3):1437-1447. doi: 10.1208/s12249-018-0965-8. Epub 2018 Feb 15. PMID: 29450829.
5: Vione D, Fabbri D, Minella M, Canonica S. Effects of the antioxidant moieties of dissolved organic matter on triplet-sensitized phototransformation processes: Implications for the photochemical modeling of sulfadiazine. Water Res. 2018 Jan 1;128:38-48. doi: 10.1016/j.watres.2017.10.020. Epub 2017 Oct 9. PMID: 29078069.
6: Hoffmann S. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature. Scand J Plast Reconstr Surg. 1984;18(1):119-26. doi: 10.3109/02844318409057413. PMID: 6377481.
7: Graves RA, Phan KV, Bostanian LA, Mandal TK, Pramar YV. Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt. Int J Pharm Compd. 2017 Sep- Oct;21(5):430-435. PMID: 29216620.
8: Chen J, Jiang X, Tong T, Miao S, Huang J, Xie S. Sulfadiazine degradation in soils: Dynamics, functional gene, antibiotic resistance genes and microbial community. Sci Total Environ. 2019 Nov 15;691:1072-1081. doi: 10.1016/j.scitotenv.2019.07.230. Epub 2019 Jul 16. PMID: 31466189.
9: Ahmed MT, Naqvi SAR, Rasheed R, Zahoor AF, Usman M, Hussain Z. Technetium-99m-Labeled Sulfadiazine: a Targeting Radiopharmaceutical for Scintigraphic Imaging of Infectious Foci Due To Escherichia coli in Mouse and Rabbit Models. Appl Biochem Biotechnol. 2017 Sep;183(1):374-384. doi: 10.1007/s12010-017-2451-2. Epub 2017 Mar 11. PMID: 28285355.
10: Zhang C, Hu L, Ding X, Lu Y, Hu G. The Role of Sulfadiazine for the Treatment of Refractory Intracranial Infection. Turk Neurosurg. 2015;25(6):895-9. doi: 10.5137/1019-5149.JTN.11920-14.1. PMID: 26617139.